AnaSpec has developed a broad portfolio of products based on fluorescence energy transfer (Fret) technology, most notably the SensoLyte line of high-performance assay kits
The detection of proteases and screening of specific protease inhibitors are critical factors in the discovery of potential drugs for the treatment and management of protease-related diseases.
In the last decade or so, the use of fluorescence resonance energy transfer (Fret) technology has made the continuous assay of protease activity and high throughput screening (HTS) of protease inhibitors faster and easier.
AnaSpec's SensoLyte line offers the industry's first and most sensitive collection of long wavelength protease assay kits.
Combining proprietary Fret technologies with world-class peptide expertise, the SensoLyte family demonstrates significantly superior performance over traditional assay kits.
The perfect overlap of absorption and emission spectrums of the SensoLyte Fret pairs allows for a level of sensitivity that is as much as 40x greater.
Showcasing this technology, AnaSpec has announced the availability of its new Fret technology brochure.
